Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 12/15 05:36:56 pm
73.55 EUR   -0.30%
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15 SANOFI : FDA lifts clinical hold on fitusiran
12/15 SANOFI : FDA lifts clinical hold on fitusiran
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CET

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
12/15 SANOFI : Aquino not yet off the hook Richard Gordon
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15 SANOFI : Solon wants Sanofi, DOH held liable for vaccine mess
12/15 NOBODY KNEW DENGVAXIA POSED RISKS : ex-president Aquino
12/15 SANOFI : Aquino confirms Paris meeting with Sanofi execs over vaccine supply
12/15 SANOFI : FDA lifts clinical hold on fitusiran
12/15 SANOFI : FDA lifts clinical hold on fitusiran
12/15 Germany's Merck in fresh bid to enter U.S. MS pill market
12/15 REGENERON PHARMACEUTICALS : and Sanofi Announce Positive Topline Pivotal Results..
12/15 REGENERON PHARMACEUTICALS : Collaboration Programs Highlighted During Sanofi Ana..
More news
News from SeekingAlpha
12/15 BIOTECH FORUM DAILY DIGEST : Impacts Of Tax Reform
12/15 FDA lifts clinical hold on Alnylam's fitusiran; shares up 6% premarket
12/14 Sanofi (SNY) Investor Presentation - Slideshow
12/14 Challenge of two Lantus patents commences
12/14 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 14, 2017
Financials (€)
Sales 2017 35 834 M
EBIT 2017 9 337 M
Net income 2017 8 158 M
Debt 2017 4 979 M
Yield 2017 4,11%
P/E ratio 2017 11,52
P/E ratio 2018 15,97
EV / Sales 2017 2,73x
EV / Sales 2018 2,68x
Capitalization 92 904 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 30
Average target price 84,1 €
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & Executive VP-Finance
Elias A. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-4.07%109 152
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386